论文部分内容阅读
目的:观察低分子肝素在不稳定性心绞痛治疗中的有效性及安全性。方法:168例不稳定性心绞痛患者随机分为两组,对照组和治疗组,治疗组在常规治疗下加用低分子肝素。结果:从心绞痛发作次数,持续时间,疼痛程度,心电图改善比较治疗组明显优于对照组,有统计学差异(P<0.05)总有效率83.7%。结论:低分子肝素是治疗不稳定性心绞痛安全有效的抗血栓形成药。
Objective: To observe the effectiveness and safety of low molecular weight heparin in the treatment of unstable angina pectoris. Methods: A total of 168 patients with unstable angina pectoris were randomly divided into two groups: the control group and the treatment group. The treatment group was given low molecular weight heparin under conventional treatment. Results: Compared with the control group, the number of episodes of angina pectoris, duration, pain degree and electrocardiogram improvement were significantly better than those of the control group (83.7%, P <0.05). Conclusion: LMWH is a safe and effective antithrombotic agent in the treatment of unstable angina pectoris.